Kim, J., Williams, A., Noh, H., Jasper, E. A., Jones, S. H., Jaworski, J. A., Shuey, M. M., Ruiz-Narváez, E. A., Wise, L. A., Palmer, J. R., Connolly, J., Keaton, J. M., Denny, J. C., Khan, A., Abbass, M. A., Rasmussen-Torvik, L. J., Kottyan, L. C., Madhivanan, P., Krupp, K., … Hellwege, J. N. (2025). Genome-wide meta-analysis identifies novel risk loci for uterine fibroids within and across multiple ancestry groups. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-57483-5

Ferris, J. S., Prest, M. T., Hur, C., Chen, L., Elkin, E. B., Melamed, A., Kong, C. Y., Myers, E. R., Havrilesky, L. J., Blank, S. V., Hazelton, W. D., & Wright, J. D. (2024). Trends in uterine cancer incidence in the United States: The contribution of age, period and cohort effects. Gynecologic Oncology, 187, 151–162. https://doi.org/10.1016/j.ygyno.2024.04.026

Advincula, A. P. (2024). Robot-assisted laparoscopic myomectomy: Technique & brief literature review. Best Practice & Research Clinical Obstetrics & Gynaecology, 93, 102452. https://doi.org/10.1016/j.bpobgyn.2023.102452

Xu, X., Chen, L., Nunez-Smith, M., Clark, M., Ferris, J. S., Hershman, D. L., & Wright, J. D. (2024). Black-White differences in uterine cancer symptomatology and stage at diagnosis. Gynecologic Oncology, 180, 118–125. https://doi.org/10.1016/j.ygyno.2023.11.029

Suzuki, Y., Chen, L., Ferris, J. S., St. Clair, C. M., Hou, J. Y., Khoury-Collado, F., Pua, T., de Meritens, A. B., Accordino, M., Hershman, D. L., & Wright, J. D. (2024). Estrogen replacement therapy and non-hormonal medication use among patients with uterine cancer. Gynecologic Oncology, 180, 14–23. https://doi.org/10.1016/j.ygyno.2023.11.010

Sereda, Y., Alarid-Escudero, F., Bickell, N. A., Chang, S.-H., Colditz, G. A., Hur, C., Jalal, H., Myers, E. R., Layne, T. M., Wang, S.-Y., Yeh, J. M., Trikalinos, T. A., Sereda, Y., Alarid-Escudero, F., Bickell, N. A., Chang, S.-H., Colditz, G. A., Hur, C., … Jalal, H. (2023). Approaches to developing de novo cancer population models to examine questions about cancer and race in bladder, gastric, and endometrial cancer and multiple myeloma: the Cancer Intervention and Surveillance Modeling Network incubator program. JNCI Monographs, 2023(62), 219–230. https://doi.org/10.1093/jncimonographs/lgad021

Ingham, M., Allred, J. B., Chen, L., Das, B., Kochupurakkal, B., Gano, K., George, S., Attia, S., Burgess, M. A., Seetharam, M., Boikos, S. A., Bui, N., Chen, J. L., Close, J. L., Cote, G. M., Thaker, P. H., Ivy, S. P., Bose, S., D’Andrea, A., … Schwartz, G. K. (2023). Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250). Journal of Clinical Oncology, 41(25), 4154–4163. https://doi.org/10.1200/jco.23.00402

Xu, X., Chen, L., Nunez-Smith, M., Clark, M., & Wright, J. D. (2023). Racial disparities in diagnostic evaluation of uterine cancer among Medicaid beneficiaries. JNCI: Journal of the National Cancer Institute, 115(6), 636–643. https://doi.org/10.1093/jnci/djad027

Li, A. H., Chen, L., Melamed, A., Hershman, D. L., & Wright, J. D. (2023). Medical and surgical retreatment for uterine leiomyoma after myomectomy. BJOG: An International Journal of Obstetrics & Gynaecology, 130(7), 835–837. Portico. https://doi.org/10.1111/1471-0528.17409

Suzuki, Y., Chen, L., Hou, J. Y., St. Clair, C. M., Khoury-Collado, F., de Meritens, A. B., Matsuo, K., Melamed, A., Hershman, D. L., & Wright, J. D. (2023). Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia. Obstetrics & Gynecology, 141(5), 979–987. https://doi.org/10.1097/aog.0000000000005124

Liao, L., Chen, L., Melamed, A., Hershman, D. L., & Wright, J. D. (2023). Use of Conservative Therapies Before Hysterectomy for Uterine Leiomyomas. Obstetrics & Gynecology, 141(2), 371–374. https://doi.org/10.1097/aog.0000000000005053

Wright, J. D., Chen, L., Melamed, A., Clair, C. M. St., Hou, J. Y., Khoury-Collado, F., Gockley, A., Accordino, M., Hershman, D. L., & Xu, X. (2022). Containment Bag Use Among Women Who Undergo Hysterectomy With Laparoscopic Power Morcellation. Obstetrics & Gynecology, 140(3), 371–380. https://doi.org/10.1097/aog.0000000000004886

Matsuo, K., Mandelbaum, R., Deshpande, R. R., Nusbaum, D. J., Yoshihara, K., Machida, H., Bainvoll, L., Matsuzaki, S., Klar, M., Roman, L. D., & Wright, J. D. (2022). Population incidence and characteristics of secondary breast cancer after uterine cancer: a competing risk analysis. Archives of Gynecology and Obstetrics, 306(3), 865–874. https://doi.org/10.1007/s00404-022-06440-4

Guo, X. M., Roman, L. D., Klar, M., Wright, J. D., & Matsuo, K. (2022). Malignant peritoneal cytology in endometrial cancer: a contemporary review. Expert Review of Anticancer Therapy, 22(9), 947–955. https://doi.org/10.1080/14737140.2022.2105208

Diggs, A., Sia, T. Y., Huang, Y., Gockley, A., Melamed, A., Khoury-Collado, F., St. Clair, C., Hou, J. Y., Hershman, D. L., & Wright, J. D. (2022). Utilization and outcomes of adjuvant therapy for stage II and III uterine leiomyosarcoma. Gynecologic Oncology, 166(2), 308–316. https://doi.org/10.1016/j.ygyno.2022.05.018

Baxter, B. L., Seaman, S. J., Arora, C., & Kim, J. H. (2022). Radiofrequency ablation methods for uterine sparing fibroid treatment. Current Opinion in Obstetrics & Gynecology, 34(4), 262–269. https://doi.org/10.1097/gco.0000000000000801

Bose, S., Schwartz, G. K., & Ingham, M. (2022). Novel Therapeutics in the Treatment of Uterine Sarcoma. American Society of Clinical Oncology Educational Book, 42, 900–909. https://doi.org/10.1200/edbk_350541

Baxter, B. L., Hur, H.-C., & Guido, R. S. (2022). Emerging Treatment Options for Fibroids. Obstetrics and Gynecology Clinics of North America, 49(2), 299–314. https://doi.org/10.1016/j.ogc.2022.03.001

Huang, Y., Hou, J. Y., Melamed, A., St. Clair, C. M., Khoury-Collado, F., Gockley, A., Ananth, C. V., Neugut, A. I., Hershman, D. L., & Wright, J. D. (2022). Pathologic characteristics, patterns of care, and outcomes of Asian-Americans and Pacific islanders with uterine cancer. Gynecologic Oncology, 165(1), 160–168. https://doi.org/10.1016/j.ygyno.2022.02.004

Polin, M., & Hur, H.-C. (2022). Radiofrequency Ablation of Uterine Myomas and Pregnancy Outcomes: An Updated Review of the Literature. Journal of Minimally Invasive Gynecology, 29(6), 709–715. https://doi.org/10.1016/j.jmig.2022.01.015

Zhou, Z. N., Chen, L., Melamed, A., St. Clair, C. M., Hou, J. Y., Khoury-Collado, F., Gockley, A., Hershman, D. L., & Wright, J. D. (2022). Adoption of minimally invasive surgery after neoadjuvant chemotherapy in women with metastatic uterine cancer. Gynecologic Oncology, 164(2), 341–347. https://doi.org/10.1016/j.ygyno.2021.12.005

Crane, E. P., Fenlon, E. P., Ascher, S. M., Balaji, D., & Siegelman, E. S. (2021). Evaluation of the Viability of Untreated Leiomyomas Using Computed Tomography–Detected Calcification Patterns. Journal of Computer Assisted Tomography, 46(1), 6–10. https://doi.org/10.1097/rct.0000000000001245